Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v9-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-01-20 | 2021-12-02 |
| Drug Identification Number | 02279525 | 02279525 |
| Brand name | D.O.R.C. VISION BLUE | D.O.R.C. VISION BLUE |
| Common or Proper name | TRYPAN BLUE 0.06 % Ophthalmic Solution | TRYPAN BLUE 0.06 % Ophthalmic Solution |
| Company Name | DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV | DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV |
| Ingredients | TRYPAN BLUE | TRYPAN BLUE |
| Strength(s) | 0.06% | 0.06% |
| Dosage form(s) | DROPS | DROPS |
| Route of administration | INTRAOCULAR INTRAOCULAR | INTRAOCULAR INTRAOCULAR |
| Packaging size | 0.5 ml/syringes | 0.5 ml/syringes |
| ATC code | S01KX | S01KX |
| ATC description | SURGICAL AIDS | SURGICAL AIDS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2021-11-17 | 2021-11-17 |
| Actual start date | 2021-11-17 | 2021-11-17 |
| Estimated end date | 2022-01-20 | 2022-01-20 |
| Actual end date | 2022-01-19 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | The increased demand for the previous lot, as well as the unexpected delay in the release of the incoming lot together, caused the shortage of this product. INNOVA Med is working with DORC and HC to try to solve this shortage as quickly as possible. | The increased demand in the previous lot, as well as the delay in the release of the incoming lot together, caused the shortage for this product. INNOVA Med is working with DORC and HC to try to solve this shortage as quickly as possible. |
| Health Canada comments |